These observations underscore the need for further investigation using AD models that incorporate both Aβ and tau pathologies better to understand the multifaceted role of CX3CR1 in disease progression (Yokoyama et al., 2022; Zhong M. Z, 2024). Here, MAPT is linked to Alzheimer disease.